Several new devices for the treatment of heart failure (HF) patients have been introduced and are increasingly used in clinical practice or are under clinical evaluation in either observational and/or randomized clinical trials. These devices include cardiac contractility modulation, spinal cord stimulation, carotid sinus nerve stimulation, cervical vagal stimulation, intracardiac atrioventricular nodal vagal stimulation, and implantable hemodynamic monitoring devices. This task force believes that an overview on these technologies is important. Special focus is given to patients with HF New York Heart Association Classes III and IV and narrow QRS complex, who represent the largest group in HF compared with patients with wide QRS complex. An overview on potential device options in addition to optimal medical therapy will be helpful for all physicians treating HF patients. © 2013 The Author.

New devices in heart failure: An European Heart Rhythm Association report / Kuck, Karl Heinz; Bordachar, Pierre; Borggrefe, Martin; Boriani, Giuseppe; Burri, Haran; Leyva, Francisco; Schauerte, Patrick; Theuns, Dominic; Thibault, Bernard; Kirchhof, Paulus; Hasenfuss, Gerhard; Dickstein, Kenneth; Leclercq, Christophe; Linde, Cecilia; Tavazzi, Luigi; Ruschitzka, Frank. - In: EUROPACE. - ISSN 1099-5129. - 16:1(2014), pp. 109-128. [10.1093/europace/eut311]

New devices in heart failure: An European Heart Rhythm Association report

BORIANI, Giuseppe;
2014

Abstract

Several new devices for the treatment of heart failure (HF) patients have been introduced and are increasingly used in clinical practice or are under clinical evaluation in either observational and/or randomized clinical trials. These devices include cardiac contractility modulation, spinal cord stimulation, carotid sinus nerve stimulation, cervical vagal stimulation, intracardiac atrioventricular nodal vagal stimulation, and implantable hemodynamic monitoring devices. This task force believes that an overview on these technologies is important. Special focus is given to patients with HF New York Heart Association Classes III and IV and narrow QRS complex, who represent the largest group in HF compared with patients with wide QRS complex. An overview on potential device options in addition to optimal medical therapy will be helpful for all physicians treating HF patients. © 2013 The Author.
2014
16
1
109
128
New devices in heart failure: An European Heart Rhythm Association report / Kuck, Karl Heinz; Bordachar, Pierre; Borggrefe, Martin; Boriani, Giuseppe; Burri, Haran; Leyva, Francisco; Schauerte, Patrick; Theuns, Dominic; Thibault, Bernard; Kirchhof, Paulus; Hasenfuss, Gerhard; Dickstein, Kenneth; Leclercq, Christophe; Linde, Cecilia; Tavazzi, Luigi; Ruschitzka, Frank. - In: EUROPACE. - ISSN 1099-5129. - 16:1(2014), pp. 109-128. [10.1093/europace/eut311]
Kuck, Karl Heinz; Bordachar, Pierre; Borggrefe, Martin; Boriani, Giuseppe; Burri, Haran; Leyva, Francisco; Schauerte, Patrick; Theuns, Dominic; Thibault, Bernard; Kirchhof, Paulus; Hasenfuss, Gerhard; Dickstein, Kenneth; Leclercq, Christophe; Linde, Cecilia; Tavazzi, Luigi; Ruschitzka, Frank
File in questo prodotto:
File Dimensione Formato  
VOR_New devices in heart failure An European Heart Rhythm Association report.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 1.05 MB
Formato Adobe PDF
1.05 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1139694
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 58
  • ???jsp.display-item.citation.isi??? 51
social impact